Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Testing advances made during the COVID-19 pandemic may lead to “test and treat” approaches for hepatitis C. But there’s a holdup.
HCV treatment initiation dropped by 31% from March to April 2020 and remained low throughout the year.
The number of people treated for hepatitis C hit a low point during the COVID-19 pandemic.
Low-barrier care and access to multiple services in one place can improve outcomes for people experiencing homelessness or unstable housing.
Health officials remain concerned about HIV and hepatitis C transmissions during COVID-19.
A Canadian hospital lab adapts two Roche diagnostic systems, allowing for over 2,000 COVID-19 tests a day. How many are in the U.S.?
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.